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Abstract: Background: Evidence links Toxoplasma gondii 
(T. gondii), a neurotropic parasite, with schizophrenia, 
mood disorders and suicidal behavior, all of which are 
associated and exacerbated by disrupted sleep. Moreover, 
low-grade immune activation and dopaminergic 
overstimulation, which are consequences of T. gondii 
infection, could alter sleep patterns and duration.
Methods: Sleep data on 833 Amish participants 
[mean age (SD) = 44.28 (16.99) years; 59.06% women] 
were obtained via self-reported questionnaires that 
assessed sleep problems, duration and timing. T. gondii 
IgG was measured with ELISA. Data were analyzed 
using multivariable logistic regressions and linear mixed 
models, with adjustment for age, sex and family structure.
Results: T. gondii seropositives reported less sleep 
problems (p < 0.005) and less daytime problems due 
to poor sleep (p < 0.005). Higher T. gondii titers were 
associated with longer sleep duration (p < 0.05), earlier 
bedtime (p < 0.005) and earlier mid-sleep time (p < 0.05). 
Conclusions: It seems unlikely that sleep mediates 
the previously reported associations between T. gondii and 
mental illness. Future longitudinal studies with objective 
measures are necessary to replicate our findings.
Keywords: IgG, mid-sleep time, sleep duration, sleep 
timing, Toxoplasma gondii.
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1  Studies and Investigations
The main investigation also includes the period between the entry into force and 
the presentation in its current version. Their function as part of the literary por-
trayal and narrative technique.
*Max Musterman: Institute of Marine Biology, National Taiwan Ocean University, 2 Pei-Ning 
Road Keelung 20224, Taiwan (R.O.C), e-mail: email@mail.com
Paul Placeholder: Institute of Marine Biology, National Taiwan Ocean University, 2 Pei-Ning 
Road Keelung 20224, Taiwan (R.O.C), e-mail: email@mail.com
 Open Access. © 2017 Mustermann and Placeholder, published by De Gruyter.  This work is 
licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
 Open Access. © 2019 Celine C. Corona et al., published by De Gruyter. Op nAccess. © 2019 KazumasaNomura and Paul Terwilliger, published byDeGruyter. This work is licensed under the Creative Commons
Attribution alone 4.0 License.
Spec. Matrices 2019; 7:1–19
Research Article Open Access
Kazumasa Nomura* and Paul Terwilliger
Self-dual Leonard pairs
https://doi.org/10.1515/spma-2019-0001
Received May 8, 2018; accepted September 22, 2018
Abstract: Let F denote a eld and let V denote a vector space over Fwith nite positive dimension. Consider
a pair A, A∗ of diagonalizable F-linear maps on V, each of which acts on an eigenbasis for the other one in an
irreducible tridiagonal fashion. Such a pair is called a Leonard pair. We consider the self-dual case in which
there exists an automorphismof the endomorphismalgebra ofV that swapsA andA∗. Such anautomorphism
is unique, and called the duality A ↔ A∗. In the present paper we give a comprehensive description of this
duality. Inparticular,wedisplay an invertibleF-linearmap T onV such that themap X → TXT−1 is theduality
A ↔ A∗. We express T as a polynomial in A and A∗. We describe how T acts on 4 ags, 12 decompositions,
and 24 bases for V.
Keywords: L onard air, tridi gon l matr x, s lf-dual
Classication: 17B37, 15A21
1 Introduction
Let F denote a eld and let V denote a vector space over F with nite positive dimension. We consider a
pair A, A∗ of diagonalizable F-linear maps on V, each of which acts on an eigenbasis for the other one in an
irreducible tridiagon l fashion. Such a pair is called a Leonard pair (see [13, Denition 1.1]). The Leonard pair
A, A∗ is said to be self-dual whenever there exists an automorphism of the endomorphism algebra of V that
swaps A and A∗. In this case such an aut morphi m is unique, and called the duality A ↔ A∗.
The literature contains any examples of self-dual Leonardpairs. For instance (i) the Leonardpair associ-
atedwith an irreduciblemodule for the Terwilliger algebra of the hypercube (see [4, Corollaries 6.8, 8.5]); (ii) a
Leonard pair of Krawtchouk type (see [10, Denition 6.1]); (iii) the Leonard pair associatedwith an irreducible
module for the Terwilliger algebra of a distance-regular graph that has a spin model in the Bose-Mesner alge-
bra (see [1, Theorem], [3, Theorems 4.1, 5.5]); (iv) an appropriately normalized totally bipartite Leonard pair
(see [11, Lemma 14.8]); (v) the Leonard pair consisting of any two of a modular Leonard triple A, B, C (see [2,
Denition 1.4]); (vi) the Leonard pair consisting of a pair of opposite generators for the q-tetrahedron alge-
bra, acting on an evaluationmodule (see [5, Proposition 9.2]). The example (i) is a special case of (ii), and the
ex mples (iii), (iv) are special cases of (v).
Let A, A∗ denote a Leonard pair on V. We can determine whether A, A∗ is self-dual in the following way.
By [13, Lemma 1.3] each eigenspace of A, A∗ has dimension one. Let {θi}di=0 denote an ordering of the eigen-
values of A. For 0 ≤ i ≤ d let vi denote a θi-eigenvector for A. The ordering {θi}di=0 is said to be standard
whenever A∗ acts on the basis {vi}di=0 in an irreducible tridiagonal fashion. If the ordering {θi}di=0 is standard
then the ordering {θd−i}di=0 is also standard, and no further ordering is standard. Similar comments apply to
A∗. Let {θi}di=0 denote a standard ordering of the eigenvalues of A. Then A, A∗ is self-dual if and only if {θi}di=0
is a standard ordering of the eigenvalues of A∗ (see [7, Proposition 8.7]).
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NREM: Non-rapid eye movement
T. gondii: Toxoplasma gondii
TNF: Tumor necrosis factor
Introduction
During infection, sleep and the immune system interact 
to improve the fitness of the host by better allocation of 
energy to critical physiological functions implicated in 
controlling the infection [1]. While the majority of studies 
focus on viral and bacterial infections, sleep is strongly 
altered in parasitic infections too. For instance, in the 
human African trypanosomiasis (sleeping sickness), there 
is a complete loss of circadian rhythm with narcoleptic-
like fits and decreased total hours of wakefulness [2]. 
Moreover, changes in sleep duration have been associated 
with parasitic infection in 12 mammalian species [3]. It 
has been suggested that sleep “fuels” the immune system 
to increase resistance to parasites [4]. Levels of cytokines 
such as interleukin (IL)-1β, IL-10, IL-12 and tumor necrosis 
factor (TNF) are at their highest during sleep, regardless 
of circadian rhythms [1]. Proinflammatory cytokine 
activity increases when a host is faced with an immune 
challenge, which leads to increased duration of non-rapid 
eye movement (NREM) sleep [4]. White blood cell counts 
have also been associated with the total sleep time in 26 
mammalian species [3]. 
Toxoplasma gondii (T. gondii) is a protozoan 
parasite estimated to have infected 30% of the world’s 
population [5]. Among Americans, the prevalence of T. 
gondii seropositivity is approximately 13.2% [6]. It has 
the ability to invade numerous warm-blooded animals 
as intermediate hosts and members of the feline family, 
who are its definitive hosts  [7]. Within the cat, T. gondii 
reproduces sexually and oocysts are formed and excreted 
into the environment where they are ingested by rodents 
and other intermediate hosts, including humans, through 
contamination of food and water  [8]. Consuming 
contaminated undercooked meat also infects humans 
[9-13]. The environment, the host’s genetic framework, the 
specific strain of T. gondii, the parasitic stage and the route 
of contamination during inoculation, all contribute to the 
severity of T. gondii infection  [14]. Many parasites  [15], 
including T. gondii  [16, 17], have the capability to change the 
behavior of their hosts to enhance the completion of their 
life cycle. The immune system of an immunocompetent 
host with chronic T. gondii infection contains the parasite 
to its slow-growing forms inside tissue cysts  [18-20]. 
There has been growing evidence that suggests increased 
rates of T. gondii infection in individuals with mental 
illness, in particular schizophrenia, including new-onset 
schizophrenia  [21, 22]. Sutterland et al. (2015) performed a 
meta-analysis and uncovered significant associations of T. 
gondii infection with schizophrenia, bipolar disorder and 
obsessive-compulsive disorder  [23]. Recently, we reported 
that T. gondii IgG serointensity was positively associated 
with cardinal symptoms of depression in the Old Order 
Amish  [24]. Links have also been identified between T. 
gondii IgG seropositivity or serointensity and suicidal 
behavior  [25-29] and with an increased risk of traffic 
accidents  [30-32]. 
Disturbances in sleep are more common and severe 
in those suffering from psychiatric conditions  [33, 34], 
including schizophrenia  [35-39], depression  [40], bipolar 
disorder  [41] and suicidal behavior [42-44], as well as car 
accidents [45], all of which, as stated above, have also been 
previously associated with T. gondii infection. We thus 
reasoned that sleep impairment might mediate, at least in 
part, the link between T. gondii infection and psychiatric 
disorders and behavioral dysregulation. Recently, we 
reported in a sample of Old Order Amish, no associations 
of T. gondii IgG seropositivity and serointensity with 
bedtime difficulties or daytime sleepiness  [46]. 
Delayed sleep phase is associated with mood 
disturbances, such as unipolar depression and bipolar 
disorder  [47]. Delayed timing and duration of sleep have 
been reported in bipolar depression  [48, 49]. Moreover, 
severity of depressive symptoms is increased in those 
with delayed timing of sleep  [50]. Sleep midpoint has 
also been reported to be delayed in those suffering from 
depression  [51]. Given these data, we expected that later 
bedtime, mid-sleep time and wake-up time would be 
positively associated with T. gondii IgG serointensity or 
seropositivity.
Given that low-grade immune activation is known 
to alter sleep  [52], together with the production by T. 
gondii of dopamine  [53, 54], a wakefulness-promoting 
neurotransmitter, we hypothesized that T. gondii would be 
associated with changes in the duration of sleep, delayed 
timing of sleep, problems maintaining sleep and increased 
daytime problems due to poor sleep. 
Methods
Study population
Data were drawn from the Amish Wellness Study, which 
began in 2010 as part of a cardio-metabolic screening 
program for the Amish community in Lancaster County, 
Unauthenticated
Download Date | 3/3/20 3:15 PM
Toxoplasma gondii IgG associations with sleep-wake problems, sleep duration and timing   3
PA, USA. Amish Research Clinic of the University of 
Maryland, Baltimore is located in Lancaster, PA, USA, and 
nurses from this clinic recruited our study subjects. The 
inclusion criteria included: belonging to the Old Order 
Amish Community, being over 18 years old, and for our 
sub-project − having responded to a variant of a sleep 
questionnaire containing the variables of interest, as well 
as having T. gondii IgG titers and seropositivity results 
from a sub-study nested in the Amish Wellness Study that 
focused on the environmental and genetic risk factors for 
T. gondii infection. Informed consent for the parent Amish 
Wellness study was obtained after a thorough explanation 
of the study by nursing staff and Amish liaisons (Old Order 
Amish women working to secure a culturally sensitive 
interface between the Amish community and the nursing 
and medical staff of the University of Maryland Baltimore 
Amish Research Clinic). The protocol for the parent 
Amish Wellness study was approved by the University of 
Maryland, Baltimore Institutional Review Board.
The study sample comprised 833 Old Order Amish 
adults [mean age (SD)=44.28 (16.99) years], which 
included 341 (40.94%) men and 492 (59.06%) women. 
They each responded to sleep questionnaires as part of a 
wellness screen in Lancaster, PA. The questionnaires were 
vetted by the Amish liaisons and by nursing personnel 
familiar with the Amish participants and culture.
Fasting blood samples were centrifuged for 25 
minutes at 400 g and at 4°C. Plasma was separated and 
stored at -80°C. To determine T. gondii serologic status, 
an enzyme-linked immunosorbent assay (ELISA) (IBL 
International, Männedorf, Switzerland) was used to test 
the plasma for IgG antibodies to T. gondii. The maximum 
dilution was 1:20. Status of each of the samples (i.e., 
seropositive or seronegative for infection with T. gondii) 
was defined by a predetermined cutoff value of 10 IU/mL, 
with a mean coefficient of variation of 7%, as reported 
by the ELISA manufacturer. When ELISA results indicated 
an equivocal concentration of T. gondii IgG (8 to 12 IU/
mL), the test was repeated. If the level was under 8 IU/
mL or over 12 IU/mL, it was considered seronegative or 
seropositive for infection with T. gondii, respectively. 
The individuals with persistent equivocal results were 
excluded from analysis. 
Informed consent: Informed consent was obtained 
from all individuals included in this study.
Ethical approval: The research related to human 
use was in compliance with all the relevant national 
regulations, institutional policies and in accordance with 
the tenets of the Helsinki Declaration, and was approved 
by the authors’ institutional review board or equivalent 
committee.
Sleep questionnaire
Selected questions were administered to measure 
our variables of interest, which were all analyzed in 
binary form. Sample sizes per variable differed due to 
the availability of T. gondii serology results in those 
subjects that had answered the sleep questionnaire. The 
questions “trouble staying asleep” (sleep maintenance), 
“problems during the day due to poor sleep” and 
“daytime sleepiness” were answered by 833 individuals, 
455 (54.62%) of which were T. gondii seropositive. Other 
questions regarding sleep that did not include the ones 
mentioned above (because of a change in questionnaire 
length due to logistical issues), were previously analyzed 
in relationship to markers of chronic T. gondii infection 
[46]. Bedtime and wake-up time were self-reported and 
the mid-sleep time was calculated. All sleep timings were 
converted to decimal hours for analysis.
Statistical methods
The relationship between T. gondii IgG seropositivity and 
transformed ranked answers from sleep questionnaires 
were analyzed using binary logistic regression, adjusted 
for age and sex (SAS version 9.3 SAS Institute Inc., Cary, 
NC, USA). The associations of T. gondii IgG titers with sleep 
duration and timing were analyzed using Linear Mixed 
Models adjusted for age, sex and family aggregation, using 
the Mixed Model Analysis for Pedigrees and Populations 
(MMAP)  [55].
Results
Digitally transformed timing of average bedtime (SD) was 
21.38 (0.54), and average wake-up time (SD) was 05.14 
(0.72). Average mid-sleep time (SD) was 01.26 (0.49). In 
analog clock-time our participants’ average bedtime was 
9:22 PM and wake-up time was 5:08 AM. 
T. gondii seropositivity and sleep parameters 
There were 455 (54.61%) T. gondii seropositive and 378 
(45.39%) T. gondii seronegative participants. Sleep 
variables in the overall sample and stratified by T. gondii 
seropositivity status are presented in Table 1. 
After adjustment for age and sex, T. gondii 
seropositivity had a significant negative association with 
difficulty staying asleep [OR 0.79, 95% CI: 0.68-0.92] and 
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problems during the day due to poor sleep [OR 0.77, 95% 
CI: 0.64-0.92].
T. gondii serointensity and sleep parameters 
T. gondii serointensity was significantly negatively 
associated with bedtime and mid-sleep time, and 
positively associated with sleep duration. Specifically, 
higher T. gondii serointensity was associated with earlier 
bedtime (β = -0.04, p = 0.0002), earlier mid-sleep time (β 
= -0.002, p = 0.02) and longer sleep duration (β = 0.04, 
p = 0.02). Wake-up time (β = -0.0009, p = 0.07) was not 
significantly changed with T. gondii serointensity (trend 
towards statistical significance). 
Discussion
To our knowledge, the current study is the first to find 
a significant association between markers of T. gondii 
infection and sleep duration, timing and maintenance, as 
well as problems during the day due to poor sleep. The 
direction of these significant associations was, in part, 
surprising. Earlier, rather than later, bedtime and mid-
sleep time, and longer rather than shorter sleep duration, 
were associated with higher T. gondii IgG titers. Moreover, 
T. gondii IgG seropositive individuals reported less, rather 
than more, difficulties in maintaining sleep and had fewer 
problems during the day due to poor sleep.
One avenue by which T. gondii may influence sleep is 
directly through its endogenous production of dopamine 
[53, 54, 56]. Evidence indicates that there is a relationship 
between dopamine and sleep-wake cycles. Patients with 
Parkinson’s disease, which reduces dopamine-producing 
neurons  [57], often have excessive daytime sleepiness 
[58]. Nishino et al. (1998) demonstrated that dopamine-
specific reuptake blockers increase wakefulness in normal 
and narcoleptic animals  [59]. Wisor et al. (2001) reported 
increased wakefulness and reduction in NREM sleep 
in mice with the absence of the dopamine transporter 
gene  [60]. A study done on dopamine (D2) receptor 
knockout mice showed decreased wakefulness, shorter 
wake periods, increased NREM sleep and increased stage 
transitions between being awake and NREM sleep  [61]. 
Additionally in this study, sleep quality was also affected, 
as indicated by the lower delta activity, a component of 
deep sleep  [61]. These data indicate the possibility that 
dopamine promotes wakefulness. 
Chronic infection with T. gondii may also promote 
daytime wakefulness, as suggested by better self-reported 
tolerance of daytime consequences of poor sleep in 
our study sample. One way to explain the wakefulness 
effect is by dopamine’s implication in homeostatic and 
Table 1: Sleep parameters and T. gondii seropositive/seronegative status.
Sleep parameters All T. gondii (+) T. gondii (-)
Trouble falling asleep (n = 829)
No 593 (71.53%) 330 (39.81%) 263 (31.72)
Yes 236 (28.47%) 122 (14.72%) 114 (13.75%)
Trouble staying asleep (n = 833)
No 415 (49.82%) 239 (28.69%) 176 (21.13%)
Yes 418 (50.18%) 216 (25.93%) 202 (24.25%)
Sleep quality (n = 828)
Poor 13 (1.57%) 5 (0.60%) 8 (0.97%)
Good 815 (98.43%) 450 (54.35%) 365 (44.08%)
Problems during the day due to poor sleep (n = 833)
No 668 (80.19%) 381 (45.74%) 287 (34.45%)
Yes 165 (19.81%) 74 (8.88%) 91 (10.92%)
Daytime sleepiness (n = 833)
No 337 (40.46%) 199 (23.89%) 138 (16.57%)
Yes 496 (59.54%) 256 (30.73%) 240 (28.81%)
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circadian components of sleep/wake regulation, which 
in turn are involved in numerous interactions with the 
neural, endocrine and immunological systems. Dopamine 
projects from the ventral tegmental area and substantia 
nigra, both of which contain functional clocks that 
schedule activities in a circadian manner  [62-64], and 
leads to the promotion of wakefulness  [58, 59, 61]. T. 
gondii can alter dopamine production in several ways. 
Firstly, it possesses tyrosine hydroxylase  [54], the rate-
limiting enzyme in dopamine production  [65]. Secondly, 
inflammation secondary to T. gondii infection may 
activate the kynurenine pathway, leading to decreased 
brain levels of kynurenic acid, higher levels of which 
have been reported to have an inverse relationship 
with dopamine levels  [66]. Thirdly, immune activation 
(necessary to contain T. gondii in immunocompetent 
hosts) may also interact with dopaminergic processes by 
inducing alterations in the level of tyrosine, the precursor 
of dopamine  [65]. A high phenylalanine:tyrosine ratio, 
resulting from inhibition of phenylalanine hydroxylase 
[67, 68], can be the consequence of Th1 activation, one 
of the central immune mechanisms responsible for 
containing T. gondii infection in immunocompetent hosts 
[69]. We recently reported how associations between T. 
gondii and aggression  [70] or impulsivity  [71], known to 
be in part modulated by dopaminergic pathways, interact 
with plasma peripheral levels of phenylalanine:tyrosine 
ratios. 
Independent of dopaminergic mechanisms, as any 
microbial organism, T. gondii can promote sleep through 
the induction of the immune system. Immune pathways 
that aid in the containment of T. gondii, as well as other 
infections in the immunocompetent host, have also been 
implicated in sleep-wake regulation. For instance, levels 
of IL-12 and TNF, both proinflammatory cytokines that 
have been linked to the acute control of T. gondii infection 
[72-75], peak during sleep regardless of circadian factors 
[1]. The activation of TNF initiates sleep  [76]. IL-10, 
an anti-inflammatory cytokine, prevents overly active 
immune response during infection  [77] and also peaks 
during sleep  [1]. It is possible that low-grade immune 
activation, potentially as a direct consequence of T. gondii 
infection, is involved in mediating the relationship of T. 
gondii IgG seropositivity and IgG titers with sleep duration 
and reduced problems in maintaining sleep. This could 
be evaluated in future longitudinal studies with multiple 
immune markers. 
The evolutionary pull of survival may, in part, be 
driving a parasite’s ability to protect sleep in its host 
thereby benefitting both host and pathogen. The host 
who sleeps longer with minimal nightly interruptions can 
have better health and may be more equipped to contain 
a pathogen through energy conservation  [1, 3], ultimately 
reducing the chance of death, other than via predation by 
a representative of the cat family. Moreover, specifically 
for T. gondii, increased activity and reduced neophobia 
during wakefulness (as described in infected rodents) 
[78], may increase chances of rodent predation by a feline, 
thus completing the parasite’s life-cycle. 
An alternative possibility is that some strains 
of T. gondii act as microbial “Old Friends” with 
immunoregulatory capabilities  [79] and subsequently, 
provide their intermediate host with a mutually beneficial 
relationship, such as less problems related to sleep, 
healthier timing and duration of sleep, with a greater 
longevity of the host, as well as a longer exposure to 
predation by the members of the cat family, eventually, 
resulting in a greater chance for T. gondii to reproduce. 
This would not be an isolated clinical link as it is known, 
for example, that T. gondii infection is associated with 
lower incidence of allergy and asthma  [80, 81], conditions 
that have also been linked to poor sleep  [82, 83]. Although 
T. gondii’s common route of infection in humans is through 
the intestinal wall, there are relatively few studies focused 
on chronic toxoplasmosis and long term consequences 
on the gut microbiome, and further on immune function 
studies in human or nonhuman animals. In one small 
study, chronic T. gondii-infected mice did have an 
increase in gut immunomodulatory bacteria compared to 
uninfected mice  [84]. 
Strengths of the study
The Amish have a relatively homogeneous lifestyle  [85] 
and have high rates of T. gondii seropositivity  [86]. Limited 
alcohol and substance use consumption, as well as the 
absence of exposure to bright or blue artificial lighting 
from television sets, cell phones and computers  [85] that 
alter the circadian rhythm and perturb sleep  [87], are 
additional strengths of our study. 
Limitations
We had a cross-sectional design, did not adjust for 
multiple comparisons (with only the negative association 
between bedtime and T. gondii IgG serointensity being 
able to resist a full adjustment for multiple comparisons, 
post hoc), and used self-report sleep measures rather than 
objective measures. Since, the study was done in the Old 
Order Amish, the generalizability of the results is limited. 
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We have not accounted for markers of inflammation and 
have not analyzed IgM and other markers to differentiate 
acute from chronic T. gondii infection. We cannot be sure if 
the lack of a significant association of titers with wake-up 
time is a result of more dominant environmental (likely 
occupational demands) factors, in comparison to mid-
sleep and bedtime, or it being a consequence of a type II 
error due to a limited sample size, resulting in a statistical 
trend rather than achieving statistical significance. 
In sum, T. gondii IgG seropositivity is associated 
with healthier sleep profiles, specifically having fewer 
problems maintaining sleep and fewer daytime problems 
due to poor sleep, and higher T. gondii IgG titers are 
associated with earlier bedtime and mid-sleep time, and 
longer sleep duration. Thus, there is no current evidence 
to support deleterious associations between T. gondii 
infection and sleep; hence, there are no grounds to 
continue to expect that sleep impairment could mediate 
the predictive associations between T. gondii infection and 
mental illness, suicidal behavior, or traffic accidents. Our 
results need to be replicated with longitudinal designs 
using objective measures of sleep. Future studies should 
also investigate potential immune mechanisms mediating 
these associations by measuring a comprehensive panel 
of inflammatory markers. For instance, given the high 
seroprevalence of T. gondii and considerable rate of 
seroconversion in the Amish, we can focus on measures of 
sleep continuity and timing on actigraphic tracing, or even 
polysomnography at baseline in T. gondii seronegative 
individuals, and then compare sleep patterns and 
differences from baseline in individuals who seroconverted 
versus those who remained seronegative. At several 
(at least two) time points, sleep questionnaires, sleep 
latency, wake-maintenance tests, sleep onset and offset 
and tests of alertness, such as the psychomotor vigilance 
tests  [88], could be related to T. gondii seropositive status, 
serointensity, cytokine profiles and potential structural 
and functional neuroimaging. Additionally, circadian 
markers, such as dim light saliva melatonin onset  [89, 
90], could lead us closer to understanding the direction of 
causality and mechanisms of the unexpected associations 
revealed by our cross-sectional study. 
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